In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual property (IP) strategy.
Patents should be the cornerstone of any life science innovator’s business strategy. Across biotechnology, pharmaceuticals, medical devices, diagnostics, robotics, AI, digital health, and advanced therapeutics, patents function as currency and leverage. Patents minimize risk in innovations, safeguarding them against competitors, attracting investors, and enabling licensing opportunities. On the other hand, weak or misaligned patent protection can undermine even the most compelling technology during due diligence.
A thoughtful, integrated patent strategy is more than a legal formality for life science innovators. It’s a vital piece of their business.
LINKS
Read "Why Patent Portfolios are Crucial for Life Science Innovators" authored by David J. Dykeman for Life Science Daily News.